Wide disparities in access to latest rheumatoid arthritis drugs across Europe
The cost of one year's treatment of rheumatoid arthritis with new generation drugs is more than the per capita gross domestic product of 26 European countries, reveals research published online in the Annals of the Rheumatic ...
Mar 6, 2013
0
0